GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal ...
A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...
Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
It’s Tuesday, Jan. 6, 2026, and today’s FSN Daily shifts from big-picture outlooks to the systems and science shaping food safety right now. We’re tracking how new tools like whole genome sequencing ...
There is no single genetic blueprint for cancer. Instead, each individual cancer draws on a collection of acquired mutations that endow the cells with a selective advantage and superior immune evasion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results